09/22/2025 | Press release | Distributed by Public on 09/22/2025 10:37
New data released by the HDA Research Foundation reveal that total sales through traditional pharmaceutical distributors grew by 10.4 percent in 2024, despite a challenging economic environment. As highlighted in the 96th Edition HDA Factbook, pharmaceutical distributor sales reached $862 billion (96 percent of all prescription drug sales); net margins after taxes continued to decline in 2024, slipping to 0.2 percent of revenue from 0.3 percent in 2023.
"This year's Factbook highlights how the healthcare distribution industry continues to remain nimble in an ever-changing business environment," said Perry Fri, Chief Industry Relations Officer and President, HDA Research Foundation. "Employee productivity continued to climb amid ongoing investments in automation and continued improvements in process enhancements. Through it all, distributors have narrowed their profit margins for the eleventh consecutive year in a row, proving they continue to be highly efficient."
Sales across customer types shifted noticeably in 2024. Chain drug stores increased to 40.5 percent, up from 36.4 percent in 2023; followed by hospitals, HMOs and clinics (15.9 percent), which decreased from 20.4 percent; specialty pharmacies (6.4 percent) increased from 5.2 percent the prior year; and, independent pharmacies (11.7 percent) fell from 13.1 percent in 2023.
[Link]View an executive summary of key HDA Factbook data for the 2024 operating year.
Published annually since 1929, the HDA Factbook is based on surveys collected at the corporate level of HDA traditional distributor member companies with annual sales greater than $1 billion. Secondary data from leading healthcare industry organizations complement the primary data to illustrate overall distributor demographics as well as trends in operations, information technology, market characteristics, customers and product mix, among other sections.
As reported within the new Factbook:
|
The 96th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2025-2026) is available as a complimentary download from HDA.org. The publication was made possible through the support of gold sponsors Apotex Corp. and Real Value Rx; silver sponsors IQVIA and R&S Northeast LLC; and bronze sponsors Ascend Laboratories, LLC and Teva Pharmaceuticals.